Autori: Andric Zoran G
| Naslov | Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC) (Article) |
| Autori | Syrigos Konstantinos Abert Istvan Andric Zoran G Bondarenko Igor N Dvorkin Mikhail Galic Kristina Galiulin Rinat Kuchava Vladimer Sriuranpong Virote Trukhin Dmytro Zhavrid Edvard Fu Dongyue Kassalow Laurent M Jones Stephanie Bashir Zahid |
| Info | BIODRUGS, (2021), vol. 35 br. 4, str. 417-428 |
| Projekat | Centus Biotherapeutics |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | HERIZON: Phase 2 part of the IMU-131 HER2/neu vaccine plus chemotherapy study randomized in patients with HER2/NEU overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction (Meeting Abstract) |
| Autori | Maglakelidze Marina ... Andric Zoran G Nikolic Ivan V ... Radosavljevic Davorin Z Petrovic Zeljko M ... (broj koautora 16) |
| Info | ANNALS OF ONCOLOGY, (2021), vol. 32 br. , Suppl. 3, str. S154-S154 |
| Projekat | Imugene Limited |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA) (Article) |
| Autori | Trukhin Dmytro ... Andric Zoran G ... (broj koautora 19) |
| Info | BIODRUGS, (2021), vol. 35 br. 4, str. 429-444 |
| Projekat | mAbxience Research SL |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | First-line avelumab in combination with cetuximab and chemotherapy in patients with advanced squamous non-small cell lung cancer (NSCLC) (Meeting Abstract) |
| Autori | Andric Zoran G ... Stojanovic Goran Petrovic Marina D ... (broj koautora 20) |
| Info | JOURNAL OF THORACIC ONCOLOGY, (2021), vol. 16 br. 4, Suppl. S, str. S753-S754 |
| Projekat | Merck KGaA, Darmstadt, Germany; Merck KGaA; Pfizer |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | IMpower110: Updated OS Analysis of Atezolizumab vs Platinum-Based Chemotherapy as First-Line Treatment in PD-L1-Selected NSCLC (Meeting Abstract) |
| Autori | Herbst Roy S ... Andric Zoran G ... (broj koautora 20) |
| Info | JOURNAL OF THORACIC ONCOLOGY, (2021), vol. 16 br. 3, Suppl. S, str. S224-S225 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study (Article) |
| Autori | Hart Lowell L Ferrarotto Renata Andric Zoran G Beck Thaddeus J Subramanian Janakiraman Radosavljevic Davorin Z Zaric Bojan Hanna Wahid T Aljumaily Raid Owonikoko Taofeek K Verhoeven Didier Xiao Jie Morris Shannon R Antal Joyce M Hussein Maen A |
| Info | ADVANCES IN THERAPY, (2021), vol. 38 br. 1, str. 350-365 |
| Projekat | G1 Therapeutics, Inc. (Research Triangle Park, NC) |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by PD-L1 immunohistochemistry (IHC) assays and blood tumour mutational burden (bTMB): IMpower110 (Meeting Abstract) |
| Autori | Herbst Roy S ... Andric Zoran G ... (broj koautora 21) |
| Info | SWISS MEDICAL WEEKLY, (2020), vol. br. , Suppl. 247, str. 31S-32S |
| Projekat | F. Hoffmann-La Roche, Ltd.Hoffmann-La Roche |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Prevention of Chemotherapy-induced Myelosuppression in SCLC patients treated with the Dual MDMX/MDM2 Inhibitor ALRN-6924 (Meeting Abstract) |
| Autori | Andric Zoran G Ceric Timur Stanetic Mirko Rancic Milan H Jakopovic Marko Aix S Ponce Ramlau Rodryg Smit E Ulanska M Caldwell C Ferrari D Annis A Vukovic V Zaric Bojan |
| Info | EUROPEAN JOURNAL OF CANCER, (2020), vol. 138 br. , Suppl. 2, str. S5-S5 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Assessment of age-related influences on the quality of life of breast cancer patients before and after surgical treatment (Article) |
| Autori | Kostic Sanja V Murtezani Zafir Andric Zoran G Ivanovic Nebojsa S Kozomara Zoran K Kostic Marko I Milicic Vesna M Kocic Sanja S |
| Info | VOJNOSANITETSKI PREGLED, (2020), vol. 77 br. 9, str. 908-916 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC (Article) |
| Autori | Herbst Roy S ... Andric Zoran G ... (broj koautora 22) |
| Info | NEW ENGLAND JOURNAL OF MEDICINE, (2020), vol. 383 br. 14, str. 1328-1339 |
| Projekat | Roche HoldingGenentech; IMpower110 ClinicalTrials.gov number [NCT02409342] |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
